REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/11/2025
Back to search
Official data from USPTO
GC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079241700Class
5, 10, 35, 42, 44
Filing
79241700
Registration
6121018
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
66
Latest update
08/12/2025
Trademark type
Combined
Nice classes
5, 10, 35, 42, 44
Filing date
05/17/2018
Registration date
08/11/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/11/2020
Last transaction
08/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
LAWRENCE, SUE
Law office
M70
Current location
PETITIONS OFFICE
Mark description
The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the letters "GC" in deep blue.
Holders and representatives
Holders
Green Cross Holdings Corporation
Representatives
Yoon S. Ham Hauptman Ham, LLP
Technical classification
Nice Classes
Class 5Class 10Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for humans used for the prevention and treatment of cancercerebrovascular thrombosismyocardial infarctionsperipheral artery occlusionspulmonary embolismsthrombocytopeniathrombophlebitisJapanese EncephalitisHepatitis B VirusHepatitis C VirusImmunodeficiency diseaseHuman Immunodeficiency Virusrare diseaseMedicines for humans used for the prevention and treatment of cancercerebrovascular thrombosismyocardial infarctionsperipheral artery occlusionspulmonary embolismsthrombocytopeniathrombophlebitisJapanese EncephalitisHepatitis B VirusHepatitis C VirusImmunodeficiency diseaseHuman Immunodeficiency Virusrare diseaseHunter SyndromeHemophiliaHemophilia Aarthritisosteoarthritisarthritis deformansperiarthritis humeroscapularistendinitisperitendinitishumeral epicondylitisidiopathic thrombocytopenic purpuraGuillain-barre syndromeKawasaki syndromeClostridium tetanivirus infectioninfluenzabacterial infection and chronic pain; Medicines for humansblood plasma-derivativesalbuminsimmunoglobulinsblood clotting factors; medicated plasters; vaccines; biological preparations for medical or veterinary purposesbiological preparations used for the prevention and treatment of cancercerebrovascular thrombosismyocardial infarctionsperipheral artery occlusionspulmonary embolismsthrombocytopeniathrombophlebitisJapanese EncephalitisHepatitis B VirusHepatitis C VirusImmunodeficiency diseaseHuman Immunodeficiency Virusrare diseaseHunter SyndromeHemophiliaHemophilia Aarthritisosteoarthritisarthritis deformansperiarthritis humeroscapularistendinitisperitendinitishumeral epicondylitisidiopathic thrombocytopenic purpuraGuillain-barre syndromeKawasaki syndromeClostridium tetanivirus infectioninfluenzabacterial infection and chronic pain; biological preparations for medical or veterinary purposesblood plasma-derivativesalbuminsimmunoglobulinsblood clotting factors
Class 10
Medical apparatus and instruments for use in performing biopsies; medical testing apparatus for medical purposesmedical apparatus for testing DNA and RNA samples; medical diagnostic apparatus and instruments for immunodiagnosis and molecular diagnosis; electromedical diagnostic instruments for immunodiagnosis and molecular diagnosis; apparatus for use in medical analysismedical apparatus for blood test; medical health signal measuring instruments for monitoring vital signs; wireless bio-signal measuring instruments for medical purposesbiofeedback sensors; precision sensors for medical useheart rhythm sensorsrespiratory sensors and biofeedback sensors; laser machining tools for medical uselasers for surgical and medical use; genetic testing apparatusapparatus for DNA and RNA testing for medical purposes
Class 35
Retail store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring medical instruments; retail store services featuring medical apparatus; retail store services featuring biological preparations for medical purposes; retail store services featuring medical genetic analyzer; retail and wholesale store services featuring pharmaceutical preparations; import-export agency services; retail store services featuring electromedical diagnostic instruments; wholesale store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring medical instruments; wholesale store services featuring medical apparatus; wholesale store services featuring biological preparations for medical purposes; wholesale store services featuring medical genetic analyzer; wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrialinstitutionalcommercial and janitorial equipment and supplies
Class 42
Research and development of vaccines and medicines; conducting clinical studies of medicines for medical research purposes; clinical research in the nature of performing biopsies for medical research; product research and development of medical products; conducting technical project studiesengineering services in the nature of technical project planning and design engineering of medical products; testinginspection or research of pharmaceuticals; scientific research relating to biology; scientific research in the field of genetic engineering; research and development of technology for biotechnology; scientific research in the fields of biomedicine; laboratory research in the field of biology; product development of cell therapy products; drug discovery services; research and development in the pharmaceutical and biotechnology fields; scientific research in the field of gene analysis; medical studiesmedical laboratory services; research and development of technology for medicinal chemical manufacturing; medical research services relating to clinical data
Class 44
Medical servicesthe removaltreatment and processing of human bloodumbilical cord bloodhuman cellsstem cells and bone marrow for medical preventivediagnostic and treatment purposes; medical examination services; health clinic servicesmedical clinics; analysis of human tissues for medical diagnosis purposes and treatment; medical consultancy for selecting appropriate medicines; human tissue bank services; medical servicesclinical pathology examination; cord blood bank services; health center services; medical and pharmaceutical consultancy; medical and health care services; pharmacy servicesdispensing of pharmaceuticals; consultancy and information services relating to the dispensing of pharmaceutical products; dispensing of pharmaceuticals; preparation and dispensing of medications; information services relating to utilization of medical products in connection with the provision of medical services; medical and health services relating to DNAgenetics and genetic testing; managed health care services
Publications
History of USPTO decisions and trademark events.
66 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/26/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/03/2020
FIMP
FINAL DISPOSITION PROCESSED
12/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/11/2020
GPNX
NOTIFICATION PROCESSED BY IB
06/12/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
06/12/2020
APET
ASSIGNED TO PETITION STAFF
06/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/26/2020
PUBO
PUBLISHED FOR OPPOSITION
05/26/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/11/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/06/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/21/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/02/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/20/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/04/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/04/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/19/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
02/19/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/19/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
02/19/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/19/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/19/2020
ISMR
WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
02/19/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2020
PUBO
PUBLISHED FOR OPPOSITION
01/14/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/25/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/25/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/30/2019
GNRT
NON-FINAL ACTION E-MAILED
07/30/2019
CNRT
NON-FINAL ACTION WRITTEN
07/30/2019
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
07/23/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/30/2019
GNSL
LETTER OF SUSPENSION E-MAILED
05/30/2019
CNSL
SUSPENSION LETTER WRITTEN
05/30/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2019
ALIE
ASSIGNED TO LIE
05/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/22/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/22/2019
RFNT
REFUSAL PROCESSED BY IB
11/24/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/02/2018
RFRR
REFUSAL PROCESSED BY MPU
11/02/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/19/2018
CNRT
NON-FINAL ACTION WRITTEN
10/18/2018
MAFR
APPLICATION FILING RECEIPT MAILED
10/13/2018
DOCK
ASSIGNED TO EXAMINER
10/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/27/2018
Continuous trademark protection
Get notified about every new filing that threatens GC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.